Medtronic stock rises as Medicare says it may cover hypertension procedure
Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...
MassDevice3d
Medtronic achieves renal denervation reimbursement milestone with CMS
Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...
Medical Design and Outsourcing1d
This Medtronic innovation ‘could be the biggest thing we ever do,’ CEO Geoff Martha says
Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...
MassDevice4d
Medtronic inks stent distro deal with Contego with option to buy
Medtronic (NYSE: MDT) announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical.
drugdeliverybusiness10h
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
medtechdive3d
CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...
Yahoo Finance1d
Medtronic plc (MDT)
After hours: 7:59:46 pm GMT-5 ...
medtechdive2d
Medical Devices
Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.